United States: Does The Medical-School-To-Prison Pipeline Widen In Middle Age?

The trend of holding physicians personally responsible for healthcare crimes has continued unabated over the past year. As noted in a previous article, physicians are particularly attractive targets for federal prosecutors due to the "special skill" and "abuse of trust" sentencing enhancements found in the U.S. Sentencing Commission Guidelines. While measuring physician participation in illegal activity is difficult, a review of U.S. Department of Justice (DOJ) press releases and select state prosecutions over a 12-month period shows that healthcare fraud appears to be the most popular charge. Common healthcare fraud violations committed by physicians involved lab schemes, medically-unnecessary services, false statements, fraudulent billing, patient-related offenses, kickbacks and bribes, and prescription drug schemes.

The following summarizes common violations of the law by physicians charged or convicted during the past year.

Common Violations of the Law by Physicians

Age Controlled Substance Violations Money Laundering Kickbacks/ Bribes False Statements Healthcare Fraud Wire/ Mail Fraud Tax Crime
30's 3 2
40's 7 4 6 14 1 3
50's 16 4 5 6 26 2 5
60's 10 2 9 2 22 3 1
70's 6 2 4 4 2 1

Based on our review of the cases in which age information was readily available, the majority of defendants were between 50 and 70 years of age, raising the question as to whether physicians in their mid-to-late years of practice commit more fraud, and if so, why. Such findings, while arguably anecdotal in nature, point to areas where healthcare and physician organizations are at risk and yield important information for developing and fine-tuning a compliance-auditing regime. In addition, with the exception of sexual assault and similar crimes, the physicians involved tended to be associated with smaller, non-institutional practices. This could be an indicator of the need for improved and continuous compliance training for physicians in smaller practices as they approach the midpoint of their careers and beyond.

The DOJ routinely emphasizes taking "a hard look" at internal business practices in an effort to identify risk and responsible individuals. To that end, providers should remain abreast of evolving risks and circumstances. The following survey of some of the reported physician criminal cases during the past year, largely from the DOJ press reports, provides useful examples of the types of activities that have landed physicians in prison.


Involving 28 physicians, the Biodiagnostic Laboratory Services referral kickback case is believed to comprise the largest number of medical professionals ever prosecuted in a kickback case. Biodiagnostic Laboratory paid kickbacks to the physicians directly in some cases and disguised as bogus lease and service agreements in others. The physicians have pleaded guilty to varying charges that have included money laundering, bribery, kickbacks, wire fraud, tax crimes and other violations. Prison sentences imposed on the physicians ranged from one to over three years.

Clinic medical director Henry Lora, M.D., 51, admitted that in exchange for bribes and kickbacks, he and his co-conspirators wrote prescriptions for home healthcare and other services for Medicare beneficiaries that were not medically necessary or not provided, and that they falsified patient records to make it appear as if the beneficiaries qualified for these services. Lora was sentenced to 108 months in prison and ordered to pay $30.3 million in restitution and to forfeit the same amount on his conviction on one count of conspiracy to commit healthcare fraud and one count of conspiracy to defraud the United States.

Rita Luthra, M.D., 64, a gynecologist, was indicted for allegedly accepting free meals and speaker fees from a pharmaceutical company in return for prescribing the company's osteoporosis drugs, for allowing pharmaceutical sales representatives to access patient records and for lying to federal investigators. A pharmaceutical manufacturer allegedly paid Luthra $23,500 to prescribe its drugs. The payments consisted of: (1) a pharmaceutical representative bringing food to Luthra's medical office 31 times and paying Luthra $750 to talk with her for 25-30 minutes while she ate, (2) catering a barbecue that Luthra hosted at her home for her friends, and (3) $250 for speaker training for Luthra, despite the fact that Luthra never spoke to any other physicians. The government alleged that Luthra's prescriptions of the company's drugs increased during the time she was paid by the company, and precipitously declined after the company stopped paying her. Luthra also allowed a PhARMA sales representative to access protected health information in her patients' medical files and provided false information to federal agents when interviewed about her relationship with the manufacturer, and allegedly directed one of her employees to also lie to investigators.

Dr. Elena Polukhin, 58, was indicted for accepting kickbacks in exchange for referring patients to a pharmacy. At Polukhin's request, the kickbacks from the pharmacy were made payable to the Roife-Nissenbaum Trust (RN Trust), a 501(c)(3) charitable trust founded by Polukhin, who also served as its chair of the board and president. The RN Trust purportedly supported several programs and services, including scholarships to students, a directory of medical providers, fitness programs, humanitarian missions and international collaborations, a mental health and chemical dependency program, medical research, and a "starving artist's project."

False Statements

Dr. Jasminka Kostic, 59, was indicted for knowingly making false statements in a document submitted to the U.S. Citizenship and Immigration Services by falsifying medical certifications to help applicants bypass tests for U.S. citizenship. The certification provided a false length of time in which a medical examination was allegedly rendered to the applicant, and a false description of the clinical methods used to diagnose the purported impairments.

Prescription Drug Schemes

In a case deemed by the DOJ as "the first in the nation involving an organized scheme to defraud government health care programs through fraudulent claims for expensive anti-psychotic medications," Dr. Kenneth Johnson, 49, was sentenced to nine years in prison for pre-signing prescription pads used by employees of Manor Medical Imaging to generate thousands of prescriptions for vulnerable identity theft victims (e.g., elderly Vietnamese beneficiaries of Medicare and Medi-Cal, military veterans recruited from drug rehab programs, and denizens of Skid Row). After the prescriptions were filled and paid for by the Medicare and Medi-Cal programs, they were sold on the black market and redistributed to pharmacies, where the drugs would be rebilled as new claims made to Medicare and Medi-Cal.

Medically Unnecessary Services

Neurosurgeon Aria O. Sabit, 39, pleaded guilty to four counts of healthcare fraud, one count of conspiracy to commit healthcare fraud and one count of unlawful distribution of a controlled substance. Sabit admitted to investing in a physician-owned distributorship (POD) and participating in an illegal kickback scheme that required the hospitals and surgical centers where he and his fellow neurosurgeons performed surgeries to purchase spinal implant devices from the POD. The physician admitted that his involvement in the POD caused him to perform medically-unnecessary spine surgeries on some of the patients and to "over instrument" his patients (using more spinal implant devices than were medically necessary to treat his patients) in order to generate sales revenue for the POD.

Farid Fata, M.D., 50, was sentenced to serve 45 years in prison and ordered to forfeit $17.6 million for his role in a healthcare fraud scheme that included administering medically unnecessary chemotherapy infusions or injections to 553 patients and providing unnecessary positron emission tomography scans. Fata also admitted to soliciting kickbacks from a hospice and home health provider in exchange for his referral of patients.

Dermatologist Robert Kolbusz, 58, was sentenced to seven years in prison for mail fraud and wire fraud in connection with his submission of "thousands of false claims to Medicare and private insurers," for treatments to destroy pre-cancerous lesions. In reality, his patients did not have pre-cancerous lesions. Many of the treatments were performed by aestheticians in his office including cosmetic laser treatments on benign skin conditions that normally would not have qualified for insurance coverage and cosmetic procedures, such as Erbium "lunchtime laser peels." Dr. Kolbusz, in one case, billed Blue Shield to remove 491 pre-cancerous lesions from a patient when in fact he performed laser procedures to lighten her freckles.

Pain specialists Drs. John Patrick Couch, 50, and Xiulu Ruan, 53, were arrested for knowingly and willfully ordering extremely expensive secondary urine drug tests, which were billed to patients' insurance providers under the false pretense that they were necessary tests, and for distributing and dispensing Schedule II controlled substances outside the usual course of professional practice and not for a legitimate medical purpose. The indictment alleged the tests were ordered primarily because of the high reimbursement paid by insurance providers for the urine tests. The indictment further alleged that the physicians upcoded services that had been performed by physician extenders, such as nurses, using their national provider identifier numbers.

Fraudulent Billing

Pain clinic owner and operator Dr. Paramjit Singh Ajrawat, 60, was sentenced to 111 months in prison for filing claims for procedures that were not performed and for over-coding procedures, according to trial evidence. Ajrawat and his wife, Sukhveen Ajrawat, 57, a licensed psychiatrist, submitted claims for nerve block injections with the use of an imaging guidance machine, equipment they neither owned nor used. The Ajrawats also falsely documented patient files to conceal the scheme from auditors and law enforcement.

Dr. Tariq Mahmood, 63, carried out a scheme to defraud Medicare and Medicaid at hospitals he owned and operated along with others by adding, changing, and incorrectly sequencing diagnostic billing codes in a way that did not reflect the patients' actual diagnoses and condition and often did so without reviewing the medical records. He was sentenced to 135 months in federal prison and ordered to pay restitution in the amount of $599,128.02.

Dr. Dennis Barson Jr., 42, received a 10-year prison sentence for fraudulently billing for rectal sensation tests and electromyogram (EMG) studies of the anal or urethral sphincter that were never performed, and for allowing unlicensed/unsupervised personnel to treat patients and then billing it as if they had been seen by a physician.

Dr. Barry Kaplowitz, 54, was convicted of making false statements related to healthcare matters and sentenced to 60 months in prison and ordered to pay more than $2.9 million in restitution. According to evidence presented at trial, Kaplowitz, who served as the medical director at a psychiatric hospital, signed false and fraudulent medical records in order to make it appear as though the hospital's patients qualified for and had received intensive outpatient services, even though they had not. The evidence demonstrated that Kaplowitz signed patient files for over 400 patients certifying that he had treated the patients notwithstanding that he neither saw nor provided any services to these patients.

As a participant in managed care plans, Dr. Isaac Kojo Anakwah Thompson, 57, received approximately 80 percent of the capitation fee for each Medicare Advantage (MA) plan beneficiary who selected the internist as their primary care physician. To increase the capitation rate, Thompson falsely diagnosed 387 MA beneficiaries with ankylosing spondylitis. He then reported these diagnoses to the MA plan, which in turn reported them to Medicare. Consequently, Medicare paid $2.1 million in excess capitation, approximately 80 percent of which went to Thompson. All or almost all of the ankylosing spondylitis diagnoses reported by Thompson were false. Thompson pled guilty to one count of healthcare fraud and could face up to 10 years in prison.

Second-Degree Murder

Dr. Hsiu-Ying "Lisa" Tseng, 46, was sentenced to serve 30 years to life in state prison after being convicted on three counts of second-degree murder and other charges after a jury found she contributed to the deaths of three patients by prescribing large amounts of unnecessary drugs. The prosecution alleged that Tseng sometimes kept no medical records of visits or patient prescriptions and faked documentation when she was being investigated.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.